Global Recombinant Protein Drugs Market Research Report 2017

February 2017 | 115 pages | ID: G907A2EEE14EN
QYResearch

Abstracts

Notes:

Production, means the output of Recombinant Protein Drugs

Revenue, means the sales value of Recombinant Protein Drugs

This report studies Recombinant Protein Drugs in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with capacity, production, price, revenue and market share for each manufacturer, covering

• Novo Nordisk
• Amgen
• Sanofi
• Eli Lilly
• Merck Serono
• Ortho Biotech
• Roche
• Kyowa Hakko Kirin
• Pharmingen
• Abcam
• GenSci
• SL PHARM
• Dongbao Pharm
• Ankebio
• NCPC
• Heng Rui

Market Segment by Regions, this report splits Global into several key Regions, with production, consumption, revenue, market share and growth rate of Recombinant Protein Drugs in these regions, from 2011 to 2021 (forecast), like

• North America
• Europe
• China
• Japan
• Southeast Asia
• India

Split by product type, with production, revenue, price, market share and growth rate of each type, can be divided into

• Type I
• Type II

Split by application, this report focuses on consumption, market share and growth rate of Recombinant Protein Drugs in each application, can be divided into

• Application 1
• Application 2

Contents

Global Recombinant Protein Drugs Market Research Report 2017

1 RECOMBINANT PROTEIN DRUGS MARKET OVERVIEW

1.1 Product Overview and Scope of Recombinant Protein Drugs
1.2 Recombinant Protein Drugs Segment by Type
  1.2.1 Global Production Market Share of Recombinant Protein Drugs by Type in 2015
  1.2.2 Type I
  1.2.3 Type II
1.3 Recombinant Protein Drugs Segment by Application
  1.3.1 Recombinant Protein Drugs Consumption Market Share by Application in 2015
  1.3.2 Application
  1.3.3 Application
1.4 Recombinant Protein Drugs Market by Region
  1.4.1 North America Status and Prospect (2012-2022)
  1.4.2 Europe Status and Prospect (2012-2022)
  1.4.3 China Status and Prospect (2012-2022)
  1.4.4 Japan Status and Prospect (2012-2022)
  1.4.5 Southeast Asia Status and Prospect (2012-2022)
  1.4.6 India Status and Prospect (2012-2022)
1.5 Global Market Size (Value) of Recombinant Protein Drugs (2012-2022)

2 GLOBAL RECOMBINANT PROTEIN DRUGS MARKET COMPETITION BY MANUFACTURERS

2.1 Global Recombinant Protein Drugs Production and Share by Manufacturers (2015 and 2016)
2.2 Global Recombinant Protein Drugs Revenue and Share by Manufacturers (2015 and 2016)
2.3 Global Recombinant Protein Drugs Average Price by Manufacturers (2015 and 2016)
2.4 Manufacturers Recombinant Protein Drugs Manufacturing Base Distribution, Sales Area and Product Type
2.5 Recombinant Protein Drugs Market Competitive Situation and Trends
  2.5.1 Recombinant Protein Drugs Market Concentration Rate
  2.5.2 Recombinant Protein Drugs Market Share of Top 3 and Top 5 Manufacturers
  2.5.3 Mergers & Acquisitions, Expansion

3 GLOBAL RECOMBINANT PROTEIN DRUGS PRODUCTION, REVENUE (VALUE) BY REGION (2012-2017)

3.1 Global Recombinant Protein Drugs Production and Market Share by Region (2012-2017)
3.2 Global Recombinant Protein Drugs Revenue (Value) and Market Share by Region (2012-2017)
3.3 Global Recombinant Protein Drugs Production, Revenue, Price and Gross Margin (2012-2017)
3.4 North America Recombinant Protein Drugs Production, Revenue, Price and Gross Margin (2012-2017)
3.5 Europe Recombinant Protein Drugs Production, Revenue, Price and Gross Margin (2012-2017)
3.6 China Recombinant Protein Drugs Production, Revenue, Price and Gross Margin (2012-2017)
3.7 Japan Recombinant Protein Drugs Production, Revenue, Price and Gross Margin (2012-2017)
3.8 Southeast Asia Recombinant Protein Drugs Production, Revenue, Price and Gross Margin (2012-2017)
3.9 India Recombinant Protein Drugs Production, Revenue, Price and Gross Margin (2012-2017)

4 GLOBAL RECOMBINANT PROTEIN DRUGS SUPPLY (PRODUCTION), CONSUMPTION, EXPORT, IMPORT BY REGIONS (2012-2017)

4.1 Global Recombinant Protein Drugs Consumption by Regions (2012-2017)
4.2 North America Recombinant Protein Drugs Production, Consumption, Export, Import (2012-2017)
4.3 Europe Recombinant Protein Drugs Production, Consumption, Export, Import (2012-2017)
4.4 China Recombinant Protein Drugs Production, Consumption, Export, Import (2012-2017)
4.5 Japan Recombinant Protein Drugs Production, Consumption, Export, Import (2012-2017)
4.6 Southeast Asia Recombinant Protein Drugs Production, Consumption, Export, Import (2012-2017)
4.7 India Recombinant Protein Drugs Production, Consumption, Export, Import (2012-2017)

5 GLOBAL RECOMBINANT PROTEIN DRUGS PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE

5.1 Global Recombinant Protein Drugs Production and Market Share by Type (2012-2017)
5.2 Global Recombinant Protein Drugs Revenue and Market Share by Type (2012-2017)
5.3 Global Recombinant Protein Drugs Price by Type (2012-2017)
5.4 Global Recombinant Protein Drugs Production Growth by Type (2012-2017)

6 GLOBAL RECOMBINANT PROTEIN DRUGS MARKET ANALYSIS BY APPLICATION

6.1 Global Recombinant Protein Drugs Consumption and Market Share by Application (2012-2017)
6.2 Global Recombinant Protein Drugs Consumption Growth Rate by Application (2012-2017)
6.3 Market Drivers and Opportunities
  6.3.1 Potential Applications
  6.3.2 Emerging Markets/Countries

7 GLOBAL RECOMBINANT PROTEIN DRUGS MANUFACTURERS PROFILES/ANALYSIS

7.1 Novo Nordisk
  7.1.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.1.2 Recombinant Protein Drugs Product Type, Application and Specification
    7.1.2.1 Product A
    7.1.2.2 Product B
  7.1.3 Novo Nordisk Recombinant Protein Drugs Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.1.4 Main Business/Business Overview
7.2 Amgen
  7.2.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.2.2 Recombinant Protein Drugs Product Type, Application and Specification
    7.2.2.1 Product A
    7.2.2.2 Product B
  7.2.3 Amgen Recombinant Protein Drugs Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.2.4 Main Business/Business Overview
7.3 Sanofi
  7.3.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.3.2 Recombinant Protein Drugs Product Type, Application and Specification
    7.3.2.1 Product A
    7.3.2.2 Product B
  7.3.3 Sanofi Recombinant Protein Drugs Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.3.4 Main Business/Business Overview
7.4 Eli Lilly
  7.4.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.4.2 Recombinant Protein Drugs Product Type, Application and Specification
    7.4.2.1 Product A
    7.4.2.2 Product B
  7.4.3 Eli Lilly Recombinant Protein Drugs Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.4.4 Main Business/Business Overview
7.5 Merck Serono
  7.5.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.5.2 Recombinant Protein Drugs Product Type, Application and Specification
    7.5.2.1 Product A
    7.5.2.2 Product B
  7.5.3 Merck Serono Recombinant Protein Drugs Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.5.4 Main Business/Business Overview
7.6 Ortho Biotech
  7.6.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.6.2 Recombinant Protein Drugs Product Type, Application and Specification
    7.6.2.1 Product A
    7.6.2.2 Product B
  7.6.3 Ortho Biotech Recombinant Protein Drugs Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.6.4 Main Business/Business Overview
7.7 Roche
  7.7.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.7.2 Recombinant Protein Drugs Product Type, Application and Specification
    7.7.2.1 Product A
    7.7.2.2 Product B
  7.7.3 Roche Recombinant Protein Drugs Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.7.4 Main Business/Business Overview
7.8 Kyowa Hakko Kirin
  7.8.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.8.2 Recombinant Protein Drugs Product Type, Application and Specification
    7.8.2.1 Product A
    7.8.2.2 Product B
  7.8.3 Kyowa Hakko Kirin Recombinant Protein Drugs Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.8.4 Main Business/Business Overview
7.9 Pharmingen
  7.9.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.9.2 Recombinant Protein Drugs Product Type, Application and Specification
    7.9.2.1 Product A
    7.9.2.2 Product B
  7.9.3 Pharmingen Recombinant Protein Drugs Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.9.4 Main Business/Business Overview
7.10 Abcam
  7.10.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.10.2 Recombinant Protein Drugs Product Type, Application and Specification
    7.10.2.1 Product A
    7.10.2.2 Product B
  7.10.3 Abcam Recombinant Protein Drugs Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.10.4 Main Business/Business Overview
7.11 GenSci
7.12 SL PHARM
7.13 Dongbao Pharm
7.14 Ankebio
7.15 NCPC
7.16 Heng Rui

8 RECOMBINANT PROTEIN DRUGS MANUFACTURING COST ANALYSIS

8.1 Recombinant Protein Drugs Key Raw Materials Analysis
  8.1.1 Key Raw Materials
  8.1.2 Price Trend of Key Raw Materials
  8.1.3 Key Suppliers of Raw Materials
  8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
  8.2.1 Raw Materials
  8.2.2 Labor Cost
  8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Recombinant Protein Drugs

9 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

9.1 Recombinant Protein Drugs Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Recombinant Protein Drugs Major Manufacturers in 2015
9.4 Downstream Buyers

10 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

10.1 Marketing Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
  10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
  10.2.1 Pricing Strategy
  10.2.2 Brand Strategy
  10.2.3 Target Client
10.3 Distributors/Traders List

11 MARKET EFFECT FACTORS ANALYSIS

11.1 Technology Progress/Risk
  11.1.1 Substitutes Threat
  11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

12 GLOBAL RECOMBINANT PROTEIN DRUGS MARKET FORECAST (2017-2022)

12.1 Global Recombinant Protein Drugs Production, Revenue and Price Forecast (2017-2022)
  12.1.1 Global Recombinant Protein Drugs Production and Growth Rate Forecast (2017-2022)
  12.1.2 Global Recombinant Protein Drugs Revenue and Growth Rate Forecast (2017-2022)
  12.1.3 Global Recombinant Protein Drugs Price and Trend Forecast (2017-2022)
12.2 Global Recombinant Protein Drugs Production, Consumption, Import and Export Forecast by Regions (2017-2022)
  12.2.1 North America Recombinant Protein Drugs Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
  12.2.2 Europe Recombinant Protein Drugs Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
  12.2.3 China Recombinant Protein Drugs Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
  12.2.4 Japan Recombinant Protein Drugs Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
  12.2.5 Southeast Asia Recombinant Protein Drugs Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
  12.2.6 India Recombinant Protein Drugs Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.3 Global Recombinant Protein Drugs Production, Revenue and Price Forecast by Type (2017-2022)
12.4 Global Recombinant Protein Drugs Consumption Forecast by Application (2017-2022)

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

Methodology
Analyst Introduction
Data Source


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Recombinant Protein Drugs
Figure Global Production Market Share of Recombinant Protein Drugs by Type in 2015
Figure Product Picture of Type I
Table Major Manufacturers of Type I
Figure Product Picture of Type II
Table Major Manufacturers of Type II
Table Recombinant Protein Drugs Consumption Market Share by Application in 2015
Figure Application 1 Examples
Figure Application 2 Examples
Figure North America Recombinant Protein Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Recombinant Protein Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure China Recombinant Protein Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Japan Recombinant Protein Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southeast Asia Recombinant Protein Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure India Recombinant Protein Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Global Recombinant Protein Drugs Revenue (Million UDS) and Growth Rate (2012-2022)
Table Global Recombinant Protein Drugs Production of Key Manufacturers (2015 and 2016)
Table Global Recombinant Protein Drugs Production Share by Manufacturers (2015 and 2016)
Figure 2015 Recombinant Protein Drugs Production Share by Manufacturers
Figure 2016 Recombinant Protein Drugs Production Share by Manufacturers
Table Global Recombinant Protein Drugs Revenue (Million USD) by Manufacturers (2015 and 2016)
Table Global Recombinant Protein Drugs Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Global Recombinant Protein Drugs Revenue Share by Manufacturers
Table 2016 Global Recombinant Protein Drugs Revenue Share by Manufacturers
Table Global Market Recombinant Protein Drugs Average Price of Key Manufacturers (2015 and 2016)
Figure Global Market Recombinant Protein Drugs Average Price of Key Manufacturers in 2015
Table Manufacturers Recombinant Protein Drugs Manufacturing Base Distribution and Sales Area
Table Manufacturers Recombinant Protein Drugs Product Type
Figure Recombinant Protein Drugs Market Share of Top 3 Manufacturers
Figure Recombinant Protein Drugs Market Share of Top 5 Manufacturers
Table Global Recombinant Protein Drugs Production by Regions (2012-2017)
Figure Global Recombinant Protein Drugs Production and Market Share by Regions (2012-2017)
Figure Global Recombinant Protein Drugs Production Market Share by Regions (2012-2017)
Figure 2015 Global Recombinant Protein Drugs Production Market Share by Regions
Table Global Recombinant Protein Drugs Revenue by Regions (2012-2017)
Table Global Recombinant Protein Drugs Revenue Market Share by Regions (2012-2017)
Table 2015 Global Recombinant Protein Drugs Revenue Market Share by Regions
Table Global Recombinant Protein Drugs Production, Revenue, Price and Gross Margin (2012-2017)
Table North America Recombinant Protein Drugs Production, Revenue, Price and Gross Margin (2012-2017)
Table Europe Recombinant Protein Drugs Production, Revenue, Price and Gross Margin (2012-2017)
Table China Recombinant Protein Drugs Production, Revenue, Price and Gross Margin (2012-2017)
Table Japan Recombinant Protein Drugs Production, Revenue, Price and Gross Margin (2012-2017)
Table Southeast Asia Recombinant Protein Drugs Production, Revenue, Price and Gross Margin (2012-2017)
Table India Recombinant Protein Drugs Production, Revenue, Price and Gross Margin (2012-2017)
Table Global Recombinant Protein Drugs Consumption Market by Regions (2012-2017)
Table Global Recombinant Protein Drugs Consumption Market Share by Regions (2012-2017)
Figure Global Recombinant Protein Drugs Consumption Market Share by Regions (2012-2017)
Figure 2015 Global Recombinant Protein Drugs Consumption Market Share by Regions
Table North America Recombinant Protein Drugs Production, Consumption, Import & Export (2012-2017)
Table Europe Recombinant Protein Drugs Production, Consumption, Import & Export (2012-2017)
Table China Recombinant Protein Drugs Production, Consumption, Import & Export (2012-2017)
Table Japan Recombinant Protein Drugs Production, Consumption, Import & Export (2012-2017)
Table Southeast Asia Recombinant Protein Drugs Production, Consumption, Import & Export (2012-2017)
Table India Recombinant Protein Drugs Production, Consumption, Import & Export (2012-2017)
Table Global Recombinant Protein Drugs Production by Type (2012-2017)
Table Global Recombinant Protein Drugs Production Share by Type (2012-2017)
Figure Production Market Share of Recombinant Protein Drugs by Type (2012-2017)
Figure 2015 Production Market Share of Recombinant Protein Drugs by Type
Table Global Recombinant Protein Drugs Revenue by Type (2012-2017)
Table Global Recombinant Protein Drugs Revenue Share by Type (2012-2017)
Figure Production Revenue Share of Recombinant Protein Drugs by Type (2012-2017)
Figure 2015 Revenue Market Share of Recombinant Protein Drugs by Type
Table Global Recombinant Protein Drugs Price by Type (2012-2017)
Figure Global Recombinant Protein Drugs Production Growth by Type (2012-2017)
Table Global Recombinant Protein Drugs Consumption by Application (2012-2017)
Table Global Recombinant Protein Drugs Consumption Market Share by Application (2012-2017)
Figure Global Recombinant Protein Drugs Consumption Market Share by Application in 2015
Table Global Recombinant Protein Drugs Consumption Growth Rate by Application (2012-2017)
Figure Global Recombinant Protein Drugs Consumption Growth Rate by Application (2012-2017)
Table Novo Nordisk Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Novo Nordisk Recombinant Protein Drugs Production, Revenue, Price and Gross Margin (2015 and 2016)
Figure Novo Nordisk Recombinant Protein Drugs Market Share (2015 and 2016)
Table Amgen Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Amgen Recombinant Protein Drugs Production, Revenue, Price and Gross Margin (2015 and 2016)
Figure Amgen Recombinant Protein Drugs Market Share (2015 and 2016)
Table Sanofi Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Sanofi Recombinant Protein Drugs Production, Revenue, Price and Gross Margin (2015 and 2016)
Figure Sanofi Recombinant Protein Drugs Market Share (2015 and 2016)
Table Eli Lilly Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Eli Lilly Recombinant Protein Drugs Production, Revenue, Price and Gross Margin (2015 and 2016)
Figure Eli Lilly Recombinant Protein Drugs Market Share (2015 and 2016)
Table Merck Serono Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Merck Serono Recombinant Protein Drugs Production, Revenue, Price and Gross Margin (2015 and 2016)
Figure Merck Serono Recombinant Protein Drugs Market Share (2015 and 2016)
Table Ortho Biotech Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Ortho Biotech Recombinant Protein Drugs Production, Revenue, Price and Gross Margin (2015 and 2016)
Figure Ortho Biotech Recombinant Protein Drugs Market Share (2015 and 2016)
Table Roche Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Roche Recombinant Protein Drugs Production, Revenue, Price and Gross Margin (2015 and 2016)
Figure Roche Recombinant Protein Drugs Market Share (2015 and 2016)
Table Kyowa Hakko Kirin Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Kyowa Hakko Kirin Recombinant Protein Drugs Production, Revenue, Price and Gross Margin (2015 and 2016)
Figure Kyowa Hakko Kirin Recombinant Protein Drugs Market Share (2015 and 2016)
Table Pharmingen Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Pharmingen Recombinant Protein Drugs Production, Revenue, Price and Gross Margin (2015 and 2016)
Figure Pharmingen Recombinant Protein Drugs Market Share (2015 and 2016)
Table Abcam Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Abcam Recombinant Protein Drugs Production, Revenue, Price and Gross Margin (2015 and 2016)
Figure Abcam Recombinant Protein Drugs Market Share (2015 and 2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Recombinant Protein Drugs
Figure Manufacturing Process Analysis of Recombinant Protein Drugs
Figure Recombinant Protein Drugs Industrial Chain Analysis
Table Raw Materials Sources of Recombinant Protein Drugs Major Manufacturers in 2015
Table Major Buyers of Recombinant Protein Drugs
Table Distributors/Traders List
Figure Global Recombinant Protein Drugs Production and Growth Rate Forecast (2017-2022)
Figure Global Recombinant Protein Drugs Revenue and Growth Rate Forecast (2017-2022)
Figure Global Recombinant Protein Drugs Price and Trend Forecast (2017-2022)
Table Global Recombinant Protein Drugs Production Forecast by Regions (2017-2022)
Table Global Recombinant Protein Drugs Consumption Forecast by Regions (2017-2022)
Figure North America Recombinant Protein Drugs Production, Revenue and Growth Rate Forecast (2017-2022)
Table North America Recombinant Protein Drugs Production, Consumption, Export and Import Forecast (2017-2022)
Figure Europe Recombinant Protein Drugs Production, Revenue and Growth Rate Forecast (2017-2022)
Table Europe Recombinant Protein Drugs Production, Consumption, Export and Import Forecast (2017-2022)
Figure China Recombinant Protein Drugs Production, Revenue and Growth Rate Forecast (2017-2022)
Table China Recombinant Protein Drugs Production, Consumption, Export and Import Forecast (2017-2022)
Figure Japan Recombinant Protein Drugs Production, Revenue and Growth Rate Forecast (2017-2022)
Table Japan Recombinant Protein Drugs Production, Consumption, Export and Import Forecast (2017-2022)
Figure Southeast Asia Recombinant Protein Drugs Production, Revenue and Growth Rate Forecast (2017-2022)
Table Southeast Asia Recombinant Protein Drugs Production, Consumption, Export and Import Forecast (2017-2022)
Figure India Recombinant Protein Drugs Production, Revenue and Growth Rate Forecast (2017-2022)
Table India Recombinant Protein Drugs Production, Consumption, Export and Import Forecast (2017-2022)
Table Global Recombinant Protein Drugs Production Forecast by Type (2017-2022)
Table Global Recombinant Protein Drugs Revenue Forecast by Type (2017-2022)
Table Global Recombinant Protein Drugs Price Forecast by Type (2017-2022)
Table Global Recombinant Protein Drugs Consumption Forecast by Application (2017-2022)